<?xml version="1.0" encoding="UTF-8"?>
<p id="p0155">To facilitate polio eradication, efforts are underway to develop improved IPVs that confer mucosal immunity and safer oral vaccines using genetically stable approaches or non-infectious virus-like particles. If successful, these new products will address the persistent risk of vaccine-derived poliovirus.</p>
